journal article·2024-11-07Open access

Near-Infrared Light Photodynamic Therapy with PEI-Capped Up-Conversion Nanoparticles and Chlorin e6 Induces Apoptosis of Oral Cancer Cells

Jinhao Cui, Yoshimasa Makita, Tomoharu Okamura, Chihoko Ikeda, Shin-ichi Fujiwara, Kazuya Tominaga

Journal of Functional Biomaterials· Volume 15· Issue 11

Abstract

Oral squamous cell carcinoma (OSCC) is a common malignancy in the oral cavity. Photodynamic therapy (PDT) is a new alternative for the treatment of diseases using photosensitizers (PS) and light. In this study, we used a photosensitizer complex (Ce6-MnNPs—Chlorin e6 combined with up-conversion nanoparticles NaYF4:Yb/Er/Mn) to investigate the therapeutic effectiveness of this treatment against oral cancer cells. We also investigated the mechanism of action of near-infrared light PDT (NIR-PDT) combined with the Ce6-MnNPs. After determining a suitable concentration of Ce6-MnNPs using an MTT assay, human oral squamous cell carcinoma cells (HSC-3) were treated with NIR-PDT with Ce6-MnNPs. We examined the characteristics of Ce6-MnNPs by transmission electron microscopy (TEM); a zeta potential and particle size analyzer; Fourier-transform infrared spectroscopy (FTIR); cell viability by MTT assay; and apoptosis by FITC-Annexin V/PI assay. The mitochondrial membrane potential (MMP), apoptosis-related mRNA level (Bax and Bcl-2) and p53 protein were also researched. NIR-PDT with 0.5 ng/µL Ce6-MnNPs inhibited the proliferation of HSC-3 (p < 0.05). After treatment with NIR-PDT, changes in the mitochondrial membrane potential and apoptosis occurred (p < 0.01). The ratio of Bax/Bcl-2 and p53-positive cells increased (p < 0.01). These results suggest that this treatment can induce apoptosis of oral cancer cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Redox biology and oxidative stress

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oral Pathology, Osaka Dental University, 8-1 Kuzuhahanazonocho, Hirakata 573-1121, Osaka, Japan

Department of Chemistry, Osaka Dental University, 8-1 Kuzuhahanazonocho, Hirakata 573-1121, Osaka, Japan

References (49)

Show source-provided references
1. Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data10.1158/1055-9965.EPI-22-0114 ↗
2. Takagi, M., Toyosawa, S., and Takata, T. (2018). Atlas of Oral Pathology, Bunkodo. [3rd ed.].
3. Oral squamous cell carcinomas: State of the field and emerging directions10.1038/s41368-023-00249-w ↗
4. Synthesized pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells10.1111/j.1600-0714.2012.01187.x ↗
5. Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro10.1016/j.oraloncology.2006.04.007 ↗
6. Photodynamic Therapy for Cancer: What’s Past is Prologue10.1111/php.13190 ↗
7. Photodynamic Therapy in Oral Cancer: A Narrative Review
8. Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma10.1021/acs.molpharmaceut.1c00510 ↗
9. Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials10.1021/acs.chemrev.0c00663 ↗
10. Alvarez, N., and Sevilla, A. (2024). Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies. Int. J. Mol. Sci., 25.10.3390/ijms25021023 ↗
11. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy10.1002/ijc.28907 ↗
12. Lipid and poly (ethylene glycol)-conjugated bi-functionalized chlorine e6 micelles for NIR-light induced photodynamic therapy10.1016/j.pdpdt.2019.101633 ↗
13. Barbora, A., Bohar, O., Sivan, A.A., Magory, E., Nause, A., and Minnes, R. (2021). Higher pulse frequency of near-infrared laser irradiation increases penetration depth for novel biomedical applications. PLoS ONE, 16.10.1371/journal.pone.0245350 ↗
14. Triple-Jump Photodynamic Theranostics: MnO2 Combined Upcon version Nanoplatforms Involving a Type-I Photosensitizer with Aggregation-Induced Emission Characteristics for Potent Cacer Treatment10.1002/adma.202103748 ↗
15. Zhao, C., and Zhou, B. (2023). Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics. J. Funct. Biomater., 14.10.3390/jfb14010012 ↗
16. Aniogo, E.C., George, B.P., and Abrahamse, H. (2021). Molecular effectors of photodynamic therapy-mediated resistance to cancer cells. Int. J. Mol. Sci., 22.10.3390/ijms222413182 ↗
17. Development of resistance to photodynamic therapy (pdt) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and ap- proaches for overcoming pdt-resistance10.1016/j.bcp.2017.08.002 ↗
18. Cell death pathways in photodynamic therapy of cancer10.3390/cancers3022516 ↗
19. Bcl-2 heterodimerizes in vivo with the conserved homologue, Bax, that accelerates programmed cell death10.1016/0092-8674(93)90509-O ↗
20. Role of p53 in Cell Death and Human Cancers10.3390/cancers3010994 ↗
21. The cellular response to p53: The decision between life and death10.1038/sj.onc.1203130 ↗
22. Live of let die: The cell’s response to p5310.1038/nrc864 ↗
23. The Gain-of-Function Mutation p53R248W Suppresses Cell Proliferation and Invasion of Oral Squamous Cell Carcinoma through the Down-Regulation of Keratin 1710.1016/j.ajpath.2020.11.011 ↗
24. Fluorescence diagnostics and photodynamic therapy of squamous cell carcinoma of the lateral surface of the tongue using the photosensitizer chlorin e6 by spectroscopic video fluorescence methods10.1088/1742-6596/2058/1/012021 ↗
25. Silverstein, R.M., Webster, F.X., and Kiemle, D.J. (2006). Spectrometric Identification of Organic Compounds, Tokyo Kagaku Dozin. [7th ed.].
26. Quality of health assessment in oral cancer patients postoperatively—A retrospective study
27. Kim, T.E., and Chang, J.E. (2023). Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials. Pharmaceutics, 15.10.3390/pharmaceutics15092257 ↗
28. Udrea, A.M., Smarandache, A., Dinache, A., Mares, C., Nistorescu, S., and Avram, S. (2023). Staicu, Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment. Pharmaceutics, 15.10.3390/pharmaceutics15082124 ↗
29. Type I AIE photosensitizers: Mechanism and application10.1002/VIW.20200121 ↗
30. Hoseini, B., Jaafari, M.R., Golabpour, A., Momtazi-Borojeni, A.A., Karimi, M., and Eslami, S. (2023). Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles. Sci. Rep., 13.10.1038/s41598-023-43689-4 ↗
31. Bioactive M(II) complexes of amino acid-based N3O donor mixed ligand: In vitro and in silico DNA binding studies10.1007/s12154-017-0170-3 ↗
32. Nanoparticle uptake: The phagocyte problem10.1016/j.nantod.2015.06.006 ↗
33. Polyethylenimine (PEI) in gene therapy: Current status and clinical applications10.1016/j.jconrel.2023.09.001 ↗
34. Sundaram, P., and Abrahamse, H. (2020). Effective Photodynamic Therapy for Colon Cancer Cells Using Chlorin e6 Coated Hyaluronic Acid-Based Carbon Nanotubes. Int. J. Mol. Sci., 21.10.3390/ijms21134745 ↗
35. Dose-Dependent Effects of Gamma Irradiation on the Materials Properties and Cell Proliferation of Electrospun Polycaprolactone Tissue Engineering Scaffolds10.1080/00914037.2014.977900 ↗
36. Elsinochrome A induces cell apoptosis and autophagy in photodynamic therapy10.1002/jcb.30451 ↗
37. Tumor regression induced by photodynamic treatment with chlorin p6 in hamster cheek pouch model of oral carcinogenesis: Dependence of mode of tumor cell death on the applied drug dose10.1016/j.oraloncology.2011.03.030 ↗
38. Programmed cell death detection methods: A systematic review and a categorical comparison10.1007/s10495-022-01735-y ↗
39. Sivandzade, F., Bhalerao, A., and Cucullo, L. (2019). Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe. Bio Protoc., 9.10.21769/BioProtoc.3128 ↗
40. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 410.1038/sj.onc.1204441 ↗
41. Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy10.1038/sj.bjc.6601298 ↗
42. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2
43. Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases10.1016/j.canlet.2005.02.030 ↗
44. p53 signaling in cancer progression and therapy10.1186/s12935-021-02396-8 ↗
45. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage10.1073/pnas.96.24.13777 ↗
46. Blinded by the light: The growing complexity of p5310.1016/j.cell.2009.04.037 ↗
47. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells
48. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function
49. Enhanced Red Upconversion Emission of NaYF4:Yb3+, Er3+, Mn2+ Nanoparticles for Near-infrared-induced Photodynamic Therapy and Fluorescence Imaging10.1246/cl.170322 ↗